Science to Consumers, Inc.
BEUT
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.38K
Close$
Share Statistics
| Market cap | $6,384.00 |
|---|---|
| Enterprise Value | $57,248.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 0.11 |
| Outstanding Shares | 31,900,000 |
Return
| Return on Equity | 86.28% |
|---|---|
| Return on Assets | -1193.87% |
| Return on Invested Capital | 68.74% |
Valuation & Multiples
| P/E Ratio | -0.11 |
|---|---|
| PEG | -4.92 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.04 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.89 |
| Debt to Equity | -0.63 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Science to Consumers, Inc.
1 employees
CEO: Ensley Edwon Lam Science to Consumers, Inc. is a burgeoning enterprise that concentrates on the promotion and sale of anti-aging cream formulas, marketed under the DermaLastyl brand. Additionally, the company is involved in the distribution of Argan oil ...